Related Experiment Video
Updated: Aug 7, 2026

05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Escitalopram-induced uveal effusions and bilateral angle closure glaucoma
Joseph R Zelefsky1, Howard F Fine, Valeria J Rubinstein
1Manhattan Eye Ear and Throat Hospital, New York, NY 10016, USA. jzelefsk@yahoo.com
American Journal of Ophthalmology
|June 13, 2006
Summary
Escitalopram use can cause acute bilateral angle closure glaucoma due to ciliochoroidal effusions. Discontinuation of the drug and corticosteroid therapy resolved the condition.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for depression.
- Angle closure glaucoma is an ophthalmic emergency characterized by increased intraocular pressure.
Observation:
- A 41-year-old woman developed acute bilateral angle closure glaucoma after initiating escitalopram.
- Ophthalmic examination revealed ciliochoroidal effusions and angle closure.
Findings:
- High-frequency ultrasonography confirmed bilateral choroidal effusions with ciliary body detachment.
- Medical management including cycloplegics, corticosteroids, and escitalopram discontinuation led to symptom resolution.
Implications:
- This case highlights a potential adverse effect of escitalopram, leading to angle closure glaucoma.
- Early recognition and management, including drug cessation, are crucial for favorable outcomes in similar cases.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...